Report World - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Sep 15, 2022

World - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Pricing Plan

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service, Privacy Policy and Licenses. We'll occasionally send you account related emails.

Overview of the Global Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses

In 2021, the global prophylactic medicaments containing insulin market decreased by -X% to $X for the first time since 2016, thus ending a four-year rising trend. In general, the total consumption indicated strong growth from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +X% against 2012 indices. Over the period under review, the global market hit record highs at $X in 2020, and then shrank modestly in the following year.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

In value terms, prophylactic medicaments containing insulin production dropped modestly to $X in 2021 estimated in export price. Overall, the total production indicated a prominent expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +X% against 2015 indices. The most prominent rate of growth was recorded in 2013 when the production volume increased by X% against the previous year. Global production peaked at $X in 2020, and then shrank slightly in the following year.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports

In 2021, global prophylactic medicaments containing insulin exports surged to X tons, increasing by X% against 2020 figures. The total export volume increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, the global exports hit record highs at X tons in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2021. Over the period under review, exports, however, continue to indicate a relatively flat trend pattern. Over the period under review, the global exports attained the peak figure at $X in 2014; however, from 2015 to 2021, the exports failed to regain momentum.

Exports by Country

France represented the major exporting country with an export of around X tons, which amounted to X% of total exports. Denmark (X tons) ranks second in terms of the total exports with a X% share, followed by the United States (X%), Italy (X%), Germany (X%), India (X%) and China (X%).

From 2012 to 2021, average annual rates of growth with regard to prophylactic medicaments containing insulin exports from France stood at +X%. At the same time, china (+X%), india (+X%), italy (+X%) and germany (+X%) displayed positive paces of growth. moreover, china emerged as the fastest-growing exporter exported in the world, with a cagr of +X% from 2012-2021. the united states experienced a relatively flat trend pattern. by contrast, denmark (-X%) illustrated a downward trend over the same period. From 2012 to 2021, the share of France, China, India and Italy increased by +X, +X, +X and +X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Germany ($X), France ($X) and Denmark ($X) appeared to be the countries with the highest levels of exports in 2021, with a combined X% share of global exports. These countries were followed by China, Italy, the United States and India, which together accounted for a further X, with a CAGR of +X%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the average prophylactic medicaments containing insulin export price amounted to $X per ton, stabilizing at the previous year. In general, the export price continues to indicate a pronounced decline. The pace of growth was the most pronounced in 2013 an increase of X% against the previous year. Over the period under review, the average export prices attained the peak figure at $X per ton in 2014; however, from 2015 to 2021, the export prices remained at a lower figure.

Prices varied noticeably countryorigin: the country with the highest price was Germany ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the other global leaders experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports

In 2021, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported worldwide; growing by X% compared with the previous year. The total import volume increased at an average annual rate of +X% from 2012 to 2021; the trend pattern remained relatively stable, with only minor fluctuations being recorded throughout the analyzed period. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin imports expanded to $X in 2021. In general, imports recorded a relatively flat trend pattern. The growth pace was the most rapid in 2013 when imports increased by X%. Global imports peaked at $X in 2014; however, from 2015 to 2021, imports remained at a lower figure.

Imports by Country

In 2021, France (X tons), followed by the United States (X tons), India (X tons), Turkey (X tons), Denmark (X tons) and Germany (X tons) represented the key importers of medicaments containing insulin but not antibiotics in measured doses, together making up X% of total imports. The following importers - the UK (X tons), China (X tons), Canada (X tons), Japan (X tons), Spain (X tons), Hungary (X tons) and Colombia (X tons) - together made up X% of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by India (with a CAGR of +X%), while imports for the other global leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin importing markets worldwide were France ($X), the United States ($X) and China ($X), together accounting for X% of global imports.

France, with a CAGR of +X%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average prophylactic medicaments containing insulin import price amounted to $X per ton, falling by -X% against the previous year. In general, the import price showed a perceptible reduction. The growth pace was the most rapid in 2020 an increase of X% against the previous year. Global import price peaked at $X per ton in 2014; however, from 2015 to 2021, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was China ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the other global leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of prophylactic medicaments containing insulin consumption in 2021 were China, the United States and India, together accounting for 52% of global consumption.
What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of prophylactic medicaments containing insulin production in 2021 were China, the United States and India, with a combined 52% share of global production.
What are the leading suppliers of medicaments containing insulin but not antibiotics in measured doses in the world?
+
In value terms, the largest prophylactic medicaments containing insulin supplying countries worldwide were Germany, France and Denmark, together accounting for 70% of global exports. These countries were followed by China, Italy, the United States and India, which together accounted for a further 24%.
What are the leading importers of medicaments containing insulin but not antibiotics in measured doses in the world?
+
In value terms, France, the United States and China were the countries with the highest levels of imports in 2021, together comprising 43% of global imports.
What is the average export price for medicaments containing insulin but not antibiotics in measured doses in the world?
+
In 2021, the average prophylactic medicaments containing insulin export price amounted to $303,042 per ton, leveling off at the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in measured doses in the world?
+
The average prophylactic medicaments containing insulin import price stood at $231,224 per ton in 2021, falling by -15.5% against the previous year.

This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Data coverage:
• Global market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Global production, split by region and country
• Global trade (exports and imports)
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
CONSUMPTION BY COUNTRY
3.3
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. GLOBAL PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
7.2
PRODUCTION BY COUNTRY
8. GLOBAL IMPORTS

The Largest Importers on The Market and How They Succeed

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. GLOBAL EXPORTS

The Largest Exporters on The Market and How They Succeed

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

11. COUNTRY PROFILES

The Largest Markets And Their Profiles

United States
China
Japan
Germany
United Kingdom
France
Brazil
Italy
Russian Federation
India
Canada
Australia
Republic of Korea
Spain
Mexico
Indonesia
Netherlands
Turkey
Saudi Arabia
Switzerland
Sweden
Nigeria
Poland
Belgium
Argentina
Norway
Austria
Thailand
United Arab Emirates
Colombia
Denmark
South Africa
Malaysia
Israel
Singapore
Egypt
Philippines
Finland
Chile
Ireland
Pakistan
Greece
Portugal
Kazakhstan
Algeria
Czech Republic
Qatar
Peru
Romania
Vietnam
LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption, By Country, 2015–2021
Table 5:
Production, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Physical Terms, By Country, 2012–2021
Table 7:
Imports, In Value Terms, By Country, 2012–2021
Table 8:
Import Prices, By Country Of Destination, 2012–2021
Table 9:
Exports, In Physical Terms, By Country, 2012–2021
Table 10:
Exports, In Value Terms, By Country, 2012–2021
Table 11:
Export Prices, By Country Of Origin, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Consumption, By Country, 2021
Figure 4:
Market Forecast To 2030
Figure 5:
Products: Market Size And Growth, By Type
Figure 6:
Products: Average Per Capita Consumption, By Type
Figure 7:
Products: Exports And Growth, By Type
Figure 8:
Products: Export Prices And Growth, By Type
Figure 9:
Production Volume And Growth
Figure 10:
Exports And Growth
Figure 11:
Export Prices And Growth
Figure 12:
Market Size And Growth
Figure 13:
Per Capita Consumption
Figure 14:
Imports And Growth
Figure 15:
Import Prices
Figure 16:
Production, In Physical Terms, 2012–2021
Figure 17:
Production, In Value Terms, 2012–2021
Figure 18:
Production, By Country, 2021
Figure 19:
Production, In Physical Terms, By Country, 2012–2021
Figure 20:
Imports, In Physical Terms, 2012–2021
Figure 21:
Imports, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, By Country, 2021
Figure 23:
Imports, In Physical Terms, By Country, 2012–2021
Figure 24:
Imports, In Value Terms, By Country, 2012–2021
Figure 25:
Import Prices, By Country, 2012–2021
Figure 26:
Exports, In Physical Terms, 2012–2021
Figure 27:
Exports, In Value Terms, 2012–2021
Figure 28:
Exports, In Physical Terms, By Country, 2021
Figure 29:
Exports, In Physical Terms, By Country, 2012–2021
Figure 30:
Exports, In Value Terms, By Country, 2012–2021
Figure 31:
Export Prices, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET